http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
xiii, 1003 pages : illustrations ; 29 cm
Scientific basis of cancer chemotherapy -- Antineoplastic drug development -- Principles of pharmacology -- Norton-Simon hypothesis -- Drug resistance -- Adjuvant chemotherapy -- Combination chemotherapy -- Combined modality therapy -- Design and interpretation of clinical trials -- Clinical trials -- Hematopoietic growth factors -- Biologic response modifiers : principles of biotherapy -- Circadian timing of cancer chemotherapy -- Intraventricular and intrathecal therapy -- Intraperitoneal chemotherapy -- Continuous intravenous infusion chemotherapy -- Intraarterial therapy -- Perfusion therapy -- Hematopoietic stem cell transplantation -- Covalent DNA-binding drugs -- Antimetabolites -- Antitumor antibiotics and related compounds -- Microtubule-targeting drugs -- DNA topoisomerase I-targeting drugs -- Differentiation agents -- Hormones -- L-asparaginase -- Investigational drugs -- Antibodies -- Hematologic complications of cancer chemotherapy -- Oral toxicity -- Dermatologic toxicity -- Extravasation -- Hypersensitivity reactions -- Ocular side effects of chemotherapy -- Cardiotoxicity of chemotherapeutic drugs -- Chemotherapy-associated lung injury -- Gastrointestinal complications of chemotherapy -- Hepatotoxicity of chemotherapeutic agents -- Renal and electrolyte abnormalities due to chemotherapy -- Neurotoxicity of chemotherapy agents -- Vascular toxicity -- Second malignancies after chemotherapy -- Chemotherapy in pregnancy -- Gonadal complications and teratogenicity of cancer therapy -- Central venous access for chemotherapy -- Risks of handling cytotoxic drugs -- Patient education -- Chemotherapy of melanoma -- Chemotherapy of primary brain tumors -- Chemotherapy of head and neck cancer -- Chemotherapy of lung cancer -- Chemotherapy of breast cancer -- Chemotherapy of gastrointestinal cancer -- Chemotherapy of endocrine tumors -- Chemotherapy of genitourinary cancers -- Chemotherapy of gynecologic cancer -- Chemotherapy of sarcomas of bone and soft tissue -- Chemotherapy of carcinoma of unknown primary site -- Chemotherapy of pediatric solid tumors -- Chemotherapy of Hodgkin's disease -- Chemotherapy of non-Hodgkin's lymphoma -- Chemotherapy of acute leukemia in adults -- Chemotherapy and immunotherapy of chronic lymphocytic leukemia and hairy cell leukemia -- Chemotherapy of the myelodysplastic syndromes -- Management of chronic myeloproliferative disorders and chronic myelocytic leukemia -- Chemotherapy of multiple myeloma and related plasma cell dyscrasias
Includes bibliographical references and index.